Description
Active GPR15L, Human Recombinant is available at Gentaur for Next week delivery.
Potent chemoattractant for lymphocytes
Biomolecule/Target:
Alternates names:
Synonyms: Antimicrobial peptide-57, AP-57, Colon-derived SUSD2 binding factor, CSBF, UNQ1833/PRO3446; Protein GPR15L; Secreted protein C10orf99
Background Information: GPR15L is a newly identified ligand for GPR15, a member of the G protein-coupled receptor (GPCR) family. Upon ligation, GPR15L acts as a potent chemoattractant for GPR15-expressing T cells and together they mediate lymphocyte recruitment to the large intestine and skin. GPR15L is constitutively expressed by colon epithelial cells where its expression is minimally altered by intestinal inflammation. Conversely, GPR15L is nearly undetectable in adult epidermis but highly upregulated during wound healing and inflammation, particularly in psoriasis. Significant expression of GPR15L is also seen in additional mucosal epithelial cells, including those of the stomach, esophagus, and urinary tract. GPR15L was first identified as an antimicrobial peptide (AMP) due to its broad spectrum of antimicrobial activity, a property shared with many chemokines. GPR15L binds to an additional receptor, SUSD2, and early studies have indicated that both are downregulated in colon cancer tissue resulting in inhibited colon cancer growth.
Reconstitution Instructions: Reconstitute to desired concentration using sterile water.
NCBI Gene Symbol:
Gene ID: 387695
NCBI Accession: Q6UWK7
Additional Information
Size: |
25 µg |
Adwords: |
False |
Country of Manufacturing Origin: |
USA |
Country of Animal Origin: |
USA |
Gene Source: |
Human |
Recombinant: |
True |
Source: |
E.coli |
Purity by SDS-PAGE: |
≥ 98% by SDS-PAGE gel and HPLC analyses |
Biological activity: |
Determined by its ability to chemoattract human PBMCs in a transwell-based migration assay. |
Molecular Weight: |
6.5 kDa |
Storage Temperature: |
-20ºC |
Shelf Life: |
12 months |
Appearance: |
Lyophilized protein |
Handling: |
Centrifuge the vial prior to opening. |